Oxford Biomedica earns U.K. nod for 4th manufacturing suite to boost COVID-19 production kblankenship Tue, 10/06/2020 – 09:06
Category: Uncategorized
Dual-energy CT adds value to routine interpretation of emergency department imaging studies by increasing radiologists’ diagnostic confidence, leading […]
NHS trusts in England have reported various risks to the safety of patients linked to staffing shortages, lack […]
Many of the arguments made by Thornley and colleagues against taking an elimination approach to covid-19 are misleading […]
Two-drug regimen continues to offer non-inferior efficacy compared to a three-drug regimen
Research tool will predict disease severity and therapeutic response
Investigational gene therapy was developed by professor Brian Bigger
Drug is ready to progress into clinical trials after passing initial safety test
Updated Date: Mon, 28 Sep 2020 00:00:00 EDT
